-Advertisement-
-Advertisement-
Industry News
Thea Pharma Inc launches preservative-free latanoprost ophthalmic solution in the U.S.
Thea Pharma Inc has launched Iyuzeh (latanoprost ophthalmic solution) 0.005% to the U.S. market, according to a press release. This preservative-free latanoprost, previously launched over a decade ago and used by around 1.5 million patients monthly across 46 countries under the brand Monoprost, is now available in the U.S. Iyuzeh...
Read More-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
Stay Connected! Join Our Newsletter
Contact
Grandin Library Building
Six Leigh Street
Clinton, New Jersey 08809
+908-505-8899
[email protected]
© 2023 Ophthalmology 360® is a trademark of International Healthcare Media, LLC. All rights Reserved